Revel Pharmaceuticals
San Francisco
About Revel Pharmaceuticals
Revel develops therapeutics for multiple diseases of aging including osteoarthritis, kidney disease, cardiovascular disease, skin aging, and complications of diabetes. It is commercializing therapeutic enzymes to degrade age-associated molecule damage.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $8.5M
- Last round: Series Unknown (Oct 2025)
- Website: revelpharmaceuticals.com
- Phone: +1 217 766 4292
Industries & Categories
Biotechnology, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/revel-pharmaceuticals-4598 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.